Deal facts
- Buyer
- Viskase Holdings, Inc.
- Target
- Viskase Companies, Inc.
- Deal value
- Not disclosed
- Announced
- 20 June 2025
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- shares
Sources
Viskase Holdings, Inc. has agreed to acquire Viskase Companies, Inc. in a strategic acquisition within the Healthcare sector. The transaction involves consideration in the form of shares, with both parties operating from the United States. The deal was announced on 20 June 2025 and subsequently completed on 26 March 2026. No specific deal value or currency was disclosed in the available records regarding this transaction.
The acquisition represents a significant consolidation within the US Healthcare market, bringing the target company under the ownership of the acquiring entity. As the transaction has already been finalised, the regulatory and operational integration processes are considered complete. The parties have successfully concluded all necessary steps to effectuate the change in ownership structure. The transaction is subject to regulatory approval.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- CompletedClosed
Viskase Holdings, Inc. completes acquisition of Viskase Companies, Inc.
Item 2.01. Completion of Acquisition or Disposition of Assets. On March 26, 2026 (the “ Closing Date ”), Viskase Holdings, Inc. (formerly known as Enzon Pharmaceuticals, Inc.) (the “ Company ” or the “ Combined Company ”) consummated the previously announced transactions pursuant to the Agreement and Plan of Merger, dated as of June 20, 2025, by and among the Company, EPSC Acquisition Corp. (“ Mer
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Circle Health Holdings Limited to acquire CHC Healthcare Holdings Limited
Circle Health Holdings Limited has agreed to acquire CHC Healthcare Holdings Limited in a strategic acquisition within the healthcare sector. Both entities are based in…
- Buyer
- Circle Health Holdings Limited
- Target
- CHC Healthcare Holdings Limited
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
GSK plc to acquire Nuvalent, Inc
GSK plc has agreed to acquire Nuvalent, Inc in a strategic acquisition valued at $10.6 billion. The transaction, announced and completed on 15 July 2026, involves full c…
- Buyer
- GSK plc
- Target
- Nuvalent, Inc
- Deal value
- USD 10,600,000,000
- Deal type
- strategic acquisition
Volex plc to acquire Kepler SignalTek Ltd
Volex plc has agreed to acquire Kepler SignalTek Ltd, a healthcare sector business based in the United Kingdom. The strategic acquisition was announced and completed on…
- Buyer
- Volex plc
- Target
- Kepler SignalTek Ltd
- Deal value
- USD 89,400,000
- Deal type
- strategic acquisition
Lixte Biotechnology Holdings, Inc. to acquire Nomad Transportable Power Systems, Inc.
Lixte Biotechnology Holdings, Inc. has agreed to acquire Nomad Transportable Power Systems, Inc. in a strategic acquisition within the Healthcare sector. The transaction…
- Buyer
- Lixte Biotechnology Holdings, Inc.
- Target
- Nomad Transportable Power Systems, Inc.
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Public Company Management Corporation to acquire Physicians Capital Management Corporation
Public Company Management Corporation has agreed to acquire Physicians Capital Management Corporation in a strategic acquisition within the healthcare sector. The transa…
- Buyer
- Public Company Management Corporation
- Target
- Physicians Capital Management Corporation
- Deal value
- Not disclosed
- Deal type
- strategic acquisition
Buyer history
Viskase Holdings, Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive